Invention Grant
- Patent Title: Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IX
- Patent Title (中): 肾细胞癌预后与碳酸酐酶的选择方法
-
Application No.: US10511465Application Date: 2003-04-15
-
Publication No.: US08936914B2Publication Date: 2015-01-20
- Inventor: Matthew H. T. Bui , David Seligson , Arie S. Belldegrun
- Applicant: Matthew H. T. Bui , David Seligson , Arie S. Belldegrun
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US03/11561 WO 20030415
- International Announcement: WO03/089659 WO 20031030
- Main IPC: C12Q1/00
- IPC: C12Q1/00 ; G01N33/53 ; G01N33/567 ; G01N33/574 ; G01N1/00 ; G01N33/48 ; G01N33/566 ; G01N33/573
Abstract:
The present invention provides methods of aiding in a renal cell carcinoma prognosis that include quantifying expressed carbonic anhydrase in samples derived from renal cell carcinoma patients. The methods also identify patients that are likely to respond positively to selected courses of treatment. The invention further provides related computer program products.
Public/Granted literature
- US20050158809A1 Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IX Public/Granted day:2005-07-21
Information query
